Innogenetics extends its diagnostics product portfolio for Alzheimer's disease with new products
22-Dec-2006 -
Innogenetics NV announced that Innogenetics has entered into a distribution agreement with Immuno-Biological Laboratories Co., Ltd. (IBL Japan). Innogenetics gains distribution rights for ELISA-based tests to determine specific forms of the beta amyloid protein, a key parameter in Alzheimer's ...
Alzheimer's disease